Key points from article :
Maximon, Europe's first longevity company builder, has opened applications for the Maximon Longevity Prize 2023, which awards CHF 50,000 (USD 56,000) to the most innovative translational longevity research project. The prize is open to any academic/non-profit scientist, innovator, student, or startup founder who has either published their breakthrough research, holds a patent, or is in very advanced stages of research.
The winners will be selected by a panel of experts in the field of longevity research and will be honored during the Longevity Investors Conference (LIC), which takes place on September 27-29th at Le Grand Bellevue Hotel in Gstaad, Switzerland.
Additionally, the winners will receive rewards from two of Maximon's ventures:
- Biolytica - personalized longevity concierge program
- Avea - one-year subscription for longevity supplements
